Search clinical trials for: Lenalidomide (Revlimid®)
Total 14684 results
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixTexas Tech UniversityNot yet recruitingCognitive Dysfunction | Neurodegenerative Disease, Hereditary | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States
-
SanofiCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
University of AthensHellenic Cooperative Oncology GroupCompleted
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Jacob Laubach, MDSanofiActive, not recruitingMultiple Myeloma | Autologous Stem Cell Transplant | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
Massachusetts General HospitalSanofi; AmgenActive, not recruiting
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
University of Heidelberg Medical CenterCompleted
-
Yvonne EfeberaBristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Beijing Friendship HospitalRecruiting
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedFollicular LymphomaFrance
-
Henan Cancer HospitalRecruiting
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterYukiguni Maitake Company Ltd.Terminated
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | B-Cell Non-Hodgkin Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
National Cancer Institute (NCI)CompletedRefractory Differentiated Thyroid Gland Carcinoma | Unresectable Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaUnited States, Canada
-
University of ArkansasWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States
-
University of Heidelberg Medical CenterActive, not recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
National Cancer Institute (NCI)Celgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Ruijin HospitalUnknown
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States